Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response.
暂无分享，去创建一个
David C. Smith | J. Taube | M. Atkins | C. Drake | F. Hodi | S. Gettinger | M. Sznol | A. Korman | J. Wigginton | A. Gupta | D. Pardoll | S. Topalian | D. Lawrence | D. Spigel | G. Kollia | S. Antonia | J. Brahmer | D. McDermott | M. Jure-Kunkel | D. McDonald